These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 6079865)

  • 21. Humoral and cellular immune factors in the systemic control of artifically induced metastases in C3Hf mice.
    Vaage J
    Cancer Res; 1973 Aug; 33(8):1957-65. PubMed ID: 4720805
    [No Abstract]   [Full Text] [Related]  

  • 22. Nonvirus-associated antigens in virus-induced mouse mammary tumors.
    Vaage J
    Cancer Res; 1968 Dec; 28(12):2477-83. PubMed ID: 4302532
    [No Abstract]   [Full Text] [Related]  

  • 23. Stability of the antigen expression in the spontaneous mammary adenocarcinoma during cultivation and absorbtion with immune serum.
    Hakim AA
    Arch Geschwulstforsch; 1977; 47(2):127-37. PubMed ID: 879981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experimental evaluation of in situ oncocide for primary tumor therapy: comparison of tumor-specific immunity after complete excision, cryonecrosis and ligation.
    Neel HB; Ketcham AS; Hammond WG
    Laryngoscope; 1973 Mar; 83(3):376-87. PubMed ID: 4690029
    [No Abstract]   [Full Text] [Related]  

  • 25. Cycling of immune responses to a syngeneic murine mammary adenocarcinoma.
    Huber SA; Bigi G; Lucas ZJ
    Cancer Res; 1980 Oct; 40(10):3484-90. PubMed ID: 6449282
    [No Abstract]   [Full Text] [Related]  

  • 26. Cellular cytotoxicity and serum inhibition in normal mice following transfer of xenogeneic tumor-sensitized cells.
    Fisher B; Wolmark N; Saffer EA
    Cancer Res; 1979 Dec; 39(12):4772-6. PubMed ID: 498106
    [No Abstract]   [Full Text] [Related]  

  • 27. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies.
    Rapp L; Fuji H
    Cancer Res; 1983 Jun; 43(6):2592-9. PubMed ID: 6342755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunity to a TA3 tumor subline that grows in allogeneic hosts elicited by strain-specific TA3 tumor cells.
    Lippman MM; Venditti JM; Kline I; Elam DL
    Cancer Res; 1973 Apr; 33(4):679-84. PubMed ID: 4696468
    [No Abstract]   [Full Text] [Related]  

  • 29. Lack of Thy 1.2 antigen expression on the surfaces of mouse mammary epithelial cells.
    Thompson K
    J Natl Cancer Inst; 1981 Jul; 67(1):143-8. PubMed ID: 6265679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro studies on tumor-specific immunity by using C3H mammary cancer-A cells. I. Inhibitory effect of lymph-node cells from the tumor bearing isologous C3H mouse on the proliferation of the tumor cells.
    Satoh K
    Acta Med Okayama (1952); 1966 Dec; 20(6):261-8. PubMed ID: 4227190
    [No Abstract]   [Full Text] [Related]  

  • 31. Transplantable mouse 16/c mammary adenocarcinoma as a model in experimental cancer therapy. II. Modification of tumor-host interactions by therapeutic procedures.
    Rak J; Strzadała L; Kuśnierczyk H; Radzikowski C
    Arch Immunol Ther Exp (Warsz); 1989; 37(3-4):379-88. PubMed ID: 2639634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Proof of the existence of antigens in virus induced mammary gland tumors of mouse line CBA-Bln].
    Zotter S; Muller M; Muschner K; Liebscher Z
    Vopr Onkol; 1973; 19(9):60-7. PubMed ID: 4363190
    [No Abstract]   [Full Text] [Related]  

  • 33. Adenocarcinoma associated antigen: enhancement of tumor growth with serum from animals bearing adenocarcinoma.
    Hakin AA
    Surg Forum; 1975; 26():175-7. PubMed ID: 1216104
    [No Abstract]   [Full Text] [Related]  

  • 34. Suppression by cytosine arabinoside of serum-blocking factors of cell-mediated immunity to syngeneic transplants of mouse mammary tumors.
    Heppner GH; Calabresi P
    J Natl Cancer Inst; 1972 Apr; 48(4):1161-7. PubMed ID: 5023677
    [No Abstract]   [Full Text] [Related]  

  • 35. Kinetics of responses to tumor antigens and mouse mammary tumor virus in BALB/cCrgl and BALB/cfC3H mice.
    Lopez DM; Sigel MM; Charyulu VL
    J Natl Cancer Inst; 1981 Jan; 66(1):191-6. PubMed ID: 6256573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mammary tumor immune enhancement in mice by local hyperemia.
    Vaage J
    Cancer Res; 1986 Jan; 46(1):386-9. PubMed ID: 3940204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro studies on tumor-specific immunity by using C3H mammary cancer-A cells. II. Specificity in growth-inhibition effect of lymph-node cells from sensitized animal on target cells.
    Satoh K
    Acta Med Okayama (1952); 1966 Dec; 20(6):269-76. PubMed ID: 4227191
    [No Abstract]   [Full Text] [Related]  

  • 38. [Immunological tumor--host relationships in mice].
    Müller M; Welcker ER; Schlotterhoss I; Henker J
    Allerg Asthma (Leipz); 1969; 15(3):157-62. PubMed ID: 4906036
    [No Abstract]   [Full Text] [Related]  

  • 39. Antitumor activity of platinum(II) complexes with histamine and radioiodinated histamine in a transplantable murine adenocarcinoma model.
    Garnuszek P; Karczmarczyk U; Maurin M
    Nucl Med Biol; 2008 Jul; 35(5):605-13. PubMed ID: 18589305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mitotic delay after fractionated irradiation of autotransplants of a spontaneous mouse tumor.
    Seydel HG
    Am J Roentgenol Radium Ther Nucl Med; 1967 Aug; 100(4):938-43. PubMed ID: 4951461
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.